NPPB and pulmonary arterial hypertension: The variables of WHO-FC, 6MWD, and BNP/NT-proBNP are included in the risk stratification of PAH prognosis according to the 2015 and 2022 European Society of Cardiology and the European Respiratory Society Guidelines [2,28].